Ab Index-Nr. 605-012-00-5

Index-Nr.Internationale chemische BezeichnungEG-Nr.CAS-Nr.EinstufungKennzeichnungbis 30.11.2018: Spezifische Konzentrations-
grenzen,
M-Faktoren
ab 01.12.2018: Spezifische Konzentrations-
grenzen
M-Faktoren und ATE
Anmer-
kungen
Gefahrenklasse, Gefahren-
kategorie und Gefahren-
kodierung
Kodierung der Gefahrenhin-
weise
Piktogramm, Kodierung der SignalworteKodierung der Gefahrenhin-
weise
Kodierung der ergänzenden Gefahren-
merkmale
605-012-00-5benzaldehyde202-860-4100-52-7Acute Tox. 4 *H302GHS07
Wng
H302   
bis 28.02.2018
605-013-00-0
chloralose (INN);
(R)-1,2-O-(2,2,2-trichloro-
ethylidene)-α-D-
glucofuranose;
glucochloralose;
anhydroglucochloral
240-016-715879-93-3Acute Tox. 4 *
Acute Tox. 4 *
H332
H302
GHS07
Wng
H332
H302
   
ab 01.03.2018*):
*) Die harmonisierten Einstufungen dürfen bereits vor dem genannten Datum verwendet werden.
605-013-00-0
Chloralose (INN);
(R)-1,2-O-(2,2,2-Trichlor-
ethyliden)-α-D-
glucofuranose;
Glucochloralose;
Anhydroglucochloral
240-016-715879-93-3Acute Tox. 4 *
Acute Tox. 3
STOT SE 3
Aquatic Acute 1
Aquatic Chronic 1
H332
H301
H336
H400
H410
GHS06
GHS09
Dgr
H332
H301
H336
H410
 M = 10
M = 10
C
605-014-00-6chloral hydrate;
2,2,2-trichloroethane-1,1-diol
206-117-5302-17-0Acute Tox. 3 *
Eye Irrit. 2
Skin Irrit. 2
H301
H319
H315
GHS06
Dgr
H301
H319
H315
   
605-015-00-11,1-diethoxyethane;
acetal
203-310-6105-57-7Flam. Liq. 2
Eye Irrit. 2
Skin Irrit. 2
H225
H319
H315
GHS02
GHS07
Dgr
H225
H319
H315
   
605-016-00-7glyoxal...%;
ethandial...%
203-474-9107-22-2Muta. 2
Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
H341
H332
H319
H315
H317
GHS07
GHS08
Wng
H341
H332
H319
H315
H317
 *B
605-017-00-21,3-dioxolane211-463-5646-06-0Flam. Liq. 2H225GHS02
Dgr
H225   
605-018-00-8propanal;
propionaldehyde
204-623-0123-38-6Flam. Liq. 2
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
H225
H319
H335
H315
GHS02
GHS07
Dgr
H225
H319
H335
H315
   
605-019-00-3citral226-394-65392-40-5Skin Irrit. 2
Skin Sens. 1
H315
H317
GHS07
Wng
H315
H317
   
605-020-00-9safrole;
5-allyl-1,3-benzodioxole
202-345-494-59-7Carc. 1B
Muta. 2
Acute Tox. 4 *
H350
H341
H302
GHS08
GHS07
Dgr
H350
H341
H302
   
605-021-00-4formaldehyde, reaction products with
butylphenol
294-145-991673-30-2Skin Sens. 1H317GHS07
Wng
H317   
bis 28.02.2018
605-022-00-X
glutaral;
glutaraldehyde;
1,5-pentanedial
203-856-5111-30-8Acute Tox. 3 *
Acute Tox. 3 *
Skin Corr. 1B
Resp. Sens. 1
Skin Sens. 1
Aquatic Acute 1
H331
H301
H314
H334
H317
H400
GHS06
GHS08
GHS05
GHS09
Dgr
H331
H301
H314
H334
H317
H400
 *
Skin Corr. 1B;
H314: C ≥ 10 %
Skin Irrit. 2;
H315: 0,5 % ≤ C < 10 %
Eye Dam. ; H318:
2 % ≤ C < 10 %
Eye Irrit. 2; H319:
0,5 % ≤ C < 2 %
STOT SE; H335:
C ≥ 0,5 %
Skin Sens. 1;
H317: C ≥ 0,5 %
 
ab 01.03.2018*):
*) Die harmonisierten Einstufungen dürfen bereits vor dem genannten Datum verwendet werden.
605-022-00-X
Glutaral;
Glutaraldehyd;
1,5-Pentanedial
203-856-5111-30-8Acute Tox. 2
Acute Tox. 3
STOT SE
Skin Corr. 1B
Resp. Sens. 1
Skin Sens. 1A
Aquatic Acute 1
Aquatic Chronic 2
H330
H301
H335
H314
H334
H317
H400
H411
GHS06
GHS05
GHS08
GHS09
Dgr
H330
H301
H335
H314
H334
H317
H410
EUH071STOT SE 3; H335:
0,5 % ≤ C < 5 %
M = 1
 
bis 30.11.2018:
605-023-00-5
5-chloro-2-(4-chlorophenoxy)phenol429-290-03380-30-1Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H318
H400
H410
GHS05
GHS09
Dgr
H318
H410
   
ab 01.12.2018*):
*) Die harmonisierten Einstufungen dürfen bereits vor dem genannten Datum verwendet werden.
605-023-00-5
5-Chloro-2-(4-chlorophenoxy)phenol;
[DCPP]
429-290-03380-30-1Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H318
H400
H410
GHS05
GHS09
Dgr
H318
H410
 M = 10
M = 10
 
605-024-00-02-bromo-5-hydroxy-4-
methoxybenzaldehyde
426-540-02973-59-3Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
   
605-025-00-6chloroacetaldehyde203-472-8107-20-0Carc. 2
Acute Tox. 2 *
Acute Tox. 3 *
Acute Tox. 3 *
Skin Corr. 1B
Aquatic Acute 1
H351
H330
H311
H301
H314
H400
GHS06
GHS08
GHS05
GHS09
Dgr
H351
H330
H311
H301
H314
H400
 STOT SE 3;
H335: C ≥ 5 %
 
605-026-00-12,5,7,7-tetramethyloctanal405-690-0114119-97-0Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
H315
H317
H411
GHS07 GHS09
Wng
H315
H317
H411
   
605-027-00-7reaction mass of: 3a,4,5,6,7,7a-hexahydro-
4,7-methano-1H-indene-6-carboxaldehyde;
3a,4,5,6,7,7a-hexahydro-4,7-
methano-1H-indene-5-
carboxaldehyde
410-480-7Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
   
605-028-00-2β-methyl-3-(1-methylethyl)-benzenepropanal412-050-4125109-85-5Aquatic Chronic 2H411GHS09H411   
605-029-00-82-cyclohexylpropanal412-270-02109-22-0Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
   
605-030-00-31-(p-methoxyphenyl)acet- aldehyde oxime411-510-13353-51-3Skin Sens. 1H317GHS07
Wng
H317   
605-031-00-9reaction mass of: 2,2-dimethoxyethanal [this component is considered to be anhydrous in terms of identity, structure and composition. However, 2,2-dimethoxyethanal will exist in a hydrated form. 60 % anhydrous is equivalent to 70.4 % hydrate; water(Including free water and water in hydrated 2,2-dimethoxyethanal)]421-890-0Skin Sens. 1H317GHS07
Wng
H317   
605-032-00-43-[3-(4-fluorophenyl)-1-(1-
methylethyl)-1H-indol-2-yl]-
(E)-2-propenal
425-370-493957-50-7Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
   
605-033-00-Xreaction mass of: 3,7,11-trimethyl-
cis-6,10-dodecadienal;
3,7,11-trimethyl-trans-6,10-
dodecadienal
425-910-932480-08-3Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H315
H400
H410
GHS07
GHS09
Wng
H315
H410
   
605-034-00-5reaction mass of:
(1RS,2RS,3SR,6RS,9SR)-9-
methoxytricyclo[5.2.1.0(2,6)]
decane-3-carbaldehyde;
(1RS,2RS,3RS,6RS,8SR)-8-
methoxytricyclo[5.2.1.0(2,6)]
decane-3-carbaldehyde;
(1RS,2RS,4SR,6RS,8SR)-8-
methoxytricyclo[5.2.1.0(2,6)]
decane-4-carbaldehyde
429-860-9Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
   
605-035-00-0(E)-3-(4-(4-fluorophenyl)-5-
methoxymethyl-2,6-bis(1-
methoxymethyl)pyridin-3-yl)prop-2-enal
426-330-9177964-68-0Eye Irrit. 2
Skin Sens. 1
Aquatic Chronic 4
H319
H317
H413
GHS07
Wng
H319
H317
H413
   
605-036-00-62-bromomalonaldehyde430-470-62065-75-0
120578-03-2
Acute Tox. 4 *
Eye Dam. 1
Aquatic Chronic 4
H302
H318
GHS05
GHS07
Dgr
H302
H318
   
605-037-00-1trans-3-[2-(7-chloro-2-
quinolinyl)vinyl]benzaldehyde;
3-[(E)-2-(7-chloro-2-
quinolinyl)vinyl]benzaldehyde
421-800-1  H413H413   
605-038-00-73-methyl-5-phenylpentan-1-al433-900-055066-49-4Acute Tox. 4 *
Skin Irrit. 2
Skin Sens. 1
Aquatic Chronic 2
H302
H315
H317
H411
GHS07
GHS09
Wng
H302
H315
H317
H411
   
605-039-00-23,4-dihydroxy-5-nitrobenzaldehyde441-810-8116313-85-0Acute Tox. 4 *
Eye Dam. 1
Skin Sens. 1
H302
H318
H317
GHS05
GHS07
Dgr
H302
H318
H317
   
ab 01.03.2018*):
*) Die harmonisierten Einstufungen dürfen bereits vor dem genannten Datum verwendet werden.
605-040-00-8
Hydroxyisohexyl-3-cyc-
lohexencarboxaldehyd (INCI);
Reaktionsmasse von
4-(4-Hydroxy-4-methyl-
pentyl)cyclohex-3-en-1-
carbaldehyd und 3-(4-
Hydroxy-4-methylpentyl)cyc-
lohex-3-en-1-carbaldehyd; [1]
4-(4-Hydroxy-4-methyl-
pentyl)cyclohex-3-en-1-
carbaldehyd; [2]
3-(4-Hydroxy-4-methyl-
pentyl)cyclohex-3-en-1-
carbaldehyd; [3]
– [1]
250-863-4 [2]
257-187-9 [3]
130066-44-3 [1]
31906-04-4 [2]
51414-25-6 [3]
Skin Sens. 1 AH317GHS07
Wng
H317   
606-001-00-8acetone;
propan-2-one;
propanone
200-662-267-64-1Flam. Liq. 2
Eye Irrit. 2
STOT SE 3
H225
H319
H336
GHS02
GHS07
Dgr
H225
H319
H336
EUH066  
606-002-00-3butanone;
ethyl methyl ketone
201-159-078-93-3Flam. Liq. 2
Eye Irrit. 2
STOT SE 3
H225
H319
H336
GHS02
GHS07
Dgr
H225
H319
H336
EUH066  
606-003-00-9heptan-3-one;
butyl ethyl ketone
203-388-1106-35-4Flam. Liq. 3
Acute Tox. 4 *
Eye Irrit. 2
H226
H332
H319
GHS02
GHS07
Wng
H226
H332
H319
   
606-004-00-44-methylpentan-2-one;
isobutyl methyl ketone
203-550-1108-10-1Flam. Liq. 2
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
H225
H332
H319
H335
GHS02
GHS07
Dgr
H225
H332
H319
H335
EUH066  
606-005-00-X2,6-dimethylheptan-4-one;
di-isobutyl ketone
203-620-1108-83-8Flam. Liq. 3
STOT SE 3
H226
H335
GHS02
GHS07
Wng
H226
H335
 STOT SE 3;
H335: C ≥ 10 %
 
606-006-00-5pentan-3-one;
diethyl ketone
202-490-396-22-0Flam. Liq. 2
STOT SE 3
STOT SE 3
H225
H335
H336
GHS02
GHS07
Dgr
H225
H335
H336
EUH066  
606-007-00-03-methylbutan-2-one;
methyl isopropyl ketone
209-264-3563-80-4Flam. Liq. 2H225GHS02
Dgr
H225   
606-009-00-14-methylpent-3-en-2-one;
mesityl oxide
205-502-5141-79-7Flam. Liq. 3
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
H226
H332
H312
H302
GHS02
GHS07
Wng
H226
H332
H312
H302
 * 
606-010-00-7cyclohexanone203-631-1108-94-1Flam. Liq. 3
Acute Tox. 4 *
H226
H332
GHS02
GHS07
Wng
H226
H332
   
606-011-00-22-methylcyclohexanone209-513-6583-60-8Flam. Liq. 3
Acute Tox. 4 *
H226
H332
GHS02
GHS07
Wng
H226
H332
   
606-012-00-83,5,5-trimethylcyclohex-2-enone;
isophorone
201-126-078-59-1Carc. 2
Acute Tox. 4 *
Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
H351
H312
H302
H319
H335
GHS08
GHS07
Wng
H351
H312
H302
H319
H335
 STOT SE 3;
H335: C ≥ 10 %
 
606-013-00-3quinone
N-methyl-2-pyrrolidone;
203-405-2106-51-4Acute Tox. 3 *
Acute Tox. 3 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
H331
H301
H319
H335
H315
H400
GHS06
GHS09
Dgr
H331
H301
H319
H335
H315
H400
 M = 10 
bis 28.02.2018
606-014-00-9
chlorophacinone (ISO);
2-(2-(4-chlorophenyl)phe-
nylacetyl)indan-
1,3-dione
223-003-03691-35-8Acute Tox. 1
Acute Tox. 2 *
Acute Tox. 3 *
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1
H310
H300
H331
H372 **
H400
H410
GHS06
GHS08
GHS09
Dgr
H310
H300
H331
H372 **
H410
   
ab 01.03.2018*):
*) Die harmonisierten Einstufungen dürfen bereits vor dem genannten Datum verwendet werden.
606-014-00-9
Chlorphacinon (ISO);
2-[(4-Chlorphenyl)(phe-
nyl)acetyl]-1H-inden-
1,3(2H)-dion
223-003-03691-35-8Repr. 1B
Acute Tox. 1
Acute Tox. 1
Acute Tox. 1
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1
H360D
H330
H310
H300
H372 (Blut)
H400
H410
GHS08
GHS06
GHS09
Dgr
H360D
H330
H310
H300
H372 (Blut)
H410
 Repr. 1B; H360D:
C ≥ 0,003 %
STOT RE 1; H372 (Blut):
C ≥ 0,1 %
STOT RE 2; H373 (Blut):
0,01 % ≤ C < 0,1 %
M = 1
M = 1
 
606-016-00-Xpindone (ISO);
2-pivaloylindan-1,3-dione
201-462-883-26-1Acute Tox. 3 *
STOT RE 1
Aquatic Acute 1
Aquatic Chronic 1
H301
H372 **
H400
H410
GHS06
GHS08
GHS09
Dgr
H301
H372 **
H410
   
606-017-00-5diketene;
diketen
211-617-1674-82-8Flam. Liq. 3
Acute Tox. 4 *
H226
H332
GHS02
GHS07
Wng
H226
H332
  D
606-018-00-0dichlone (ISO);
2,3-dichloro-1,4-naphthoquinone
204-210-5117-80-6Acute Tox. 4 *
Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H302
H319
H315
H400
H410
GHS07
GHS09
Wng
H302
H319
H315
H410
   
606-019-00-6chlordecone (ISO);
perchloropentacyclo[5,3,0,02,6,03,9,04,8]
decan-5-one;
decachloropentacyclo[5,2,1,02,6,03,9,05,8]
decan-4-one
205-601-3143-50-0Carc. 2
Acute Tox. 3 *
Acute Tox. 3 *
Aquatic Acute 1
Aquatic Chronic 1
H351
H311
H301
H400
H410
GHS06
GHS08
GHS09
Dgr
H351
H311
H301
H410
   
606-020-00-15-methylheptan-3-one208-793-7541-85-5Flam. Liq. 3
Eye Irrit. 2
STOT SE 3
H226
H319
H335
GHS02
GHS07
Wng
H226
H319
H335
 STOT SE 3;
H335: C ≥ 10 %
 
bis 28.02.2018
606-021-00-7
1-methyl-2-pyrrolidone212-828-1872-50-4Repr. 1B
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
H360D ***
H319
H335
H315
GHS08
GHS07
Dgr
H360D ***
H319
H335
H315
 Repr. 1B;
H360D:
C ≥ 5 %
STOT SE 3;
H335:
C ≥ 10 %
 
ab 01.03.2018*):
*) Die harmonisierten Einstufungen dürfen bereits vor dem genannten Datum verwendet werden.
606-021-00-7
N-Methyl-2-pyrrolidon;
1-Methyl-2-pyrrolidon
212-828-1872-50-4Repr. 1B
STOT SE 3
Skin Irrit. 2
Eye Irrit. 2
H360D ***
H335
H315
H319
GHS08
GHS07
Dgr
H360D ***
H335
H315
H319
 STOT SE 3; H335:
C ≥ 10 %
 
606-022-00-21-phenyl-3-pyrazolidone202-155-192-43-3Acute Tox. 4 *
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Wng
H302
H411
   
606-023-00-84-methoxy-4-methylpentan-2-one203-512-4107-70-0Flam. Liq. 3
Acute Tox. 4
((*))
H226
H332
GHS02
GHS07
Wng
H226
H332
   
606-024-00-3heptan-2-one;
methyl amyl ketone
203-767-1110-43-0Flam. Liq. 3
Acute Tox. 4 (*)
Acute Tox. 4 (*)
H226
H332
H302
GHS02
GHS07
Wng
H226
H332
H302
   
606-025-00-9cyclopentanone204-435-9120-92-3Flam. Liq. 3
Eye Irrit. 2
Skin Irrit. 2
H226
H319
H315
GHS02
GHS07
Wng
H226
H319
H315
   
606-026-00-45-methylhexan-2-one;
isoamyl methyl ketone
203-737-8110-12-3Flam. Liq. 3
Acute Tox. 4 (*)
H226
H332
GHS02
GHS07
Wng
H226
H332
   
606-027-00-Xheptan-4-one;
di-n-propyl ketone
204-608-9123-19-3Flam. Liq. 3
Acute Tox. 4 (*)
H226
H332
GHS02
GHS07
Wng
H226
H332
   
606-028-00-52,4-dimethylpentan-3-one;
di-isopropyl ketone
209-294-7565-80-0Flam. Liq. 2
Acute Tox. 4 (*)
H225
H332
GHS02
GHS07
Dgr
H225
H332
   
606-029-00-0pentane-2,4-dione;
acetylacetone
204-634-0123-54-6Flam. Liq. 3
Acute Tox. 4 (*)
H226
H302
GHS02
GHS07
Wng
H226
H302
   
606-030-00-6hexan-2-one;
methyl butyl ketone;
butyl methyl ketone;
methyl-n-butyl ketone
209-731-1591-78-6Flam. Liq. 3
Repr. 2
STOT RE 1
STOT SE 3
H226
H361f
(*)(*)(*)
H372 (*)(*)
H336
GHS02
GHS08
GHS07
Dgr
H226
H361f
(*)(*)(*)
H372 (*)(*)
H336
   
606-031-00-13-propanolide;
1,3-propiolactone
200-340-157-57-8Carc. 1B
Acute Tox. 2 (*)
Eye Irrit. 2
Skin Irrit. 2
H350
H330
H319
H315
GHS06
GHS08
Dgr
H350
H330
H319
H315
   
606-032-00-7hexachloroacetone204-129-5116-16-5Acute Tox. 4 (*)
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Wng
H302
H411
   
606-033-00-22-(3,4-dichlorophenyl)-4-methyl-1,2,4-oxadiazolidinedione;
methazole
243-761-620354-26-1Acute Tox. 4 (*)
Acute Tox. 4 (*)
Eye Irrit. 2
Skin Irrit. 2
Aquatic Chronic 2
H312
H302
H319
H315
H411
GHS07
GHS09
Wng
H312
H302
H319
H315
H411
   
606-034-00-8metribuzin (ISO);
4-amino-6-tert-butyl-3-methylthio-1,2,4-
triazin-5(4H)-one;
4-amino-4,5-dihydro-6-(1,1-dimethylethyl)-3-
methylthio-1,2,4-triazin-5-one
244-209-721087-64-9Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410
 M = 10 
606-035-00-3chloridazon (ISO);
5-amino-4-chloro-2-phenylpyridazine-3-
(2H)-one;
pyrazon
216-920-21698-60-8Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
   
606-036-00-9quinomethionate;
chinomethionat (ISO);
6-methyl-1,3-dithiolo(4,5-b)qui-
noxalin-2-one
219-455-32439-01-2Repr. 2
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)
STOT RE 2 (*)
Eye Irrit. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H361f
(*)(*)(*)
H332
H312
H302
H373(*)(*)
H319
H317
H400
H410
GHS08
GHS07
GHS09
Wng
H361f
(*)(*)(*)
H332
H312
H302
H373 (*)(*)
H319
H317
H410
   
606-037-00-4triadimefon (ISO);
1-(4-chlorophenoxy)-3,3-dimethyl-1-(1,2,4-
triazol-1-yl)butanone
256-103-843121-43-3Acute Tox. 4 (*)
Skin Sens. 1
Aquatic Chronic 2
H302
H317
H411
GHS07
GHS09
Wng
H302
H317
H411
   
606-038-00-Xdiphacinone (ISO);
2-diphenylacetylindan-1,3-dione
201-434-582-66-6Acute Tox. 2 (*)
STOT RE 1
H300
H372 (*)(*)
GHS06
GHS08
Dgr
H300
H372 (*)(*)
   
606-039-00-55(or 6)-tert-butyl-2'-chloro-6'-
ethylamino-3',7'-dimethyl-
spiro(isobenzofuran-1(1H),9'-
xanthene)-3-one
400-680-2Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1
H332
H400
H410
GHS07
GHS09
Wng
H332
H410
   
606-040-00-0(N-benzyl-N-ethyl)amino-3-
hydroxyacetophenone hydrochloride
401-840-455845-90-4Eye Dam. 1
Aquatic Chronic 2
H318
H411
GHS05
GHS09
Dgr
H318
H411
   
bis 30.11.2018:
606-041-00-6
2-methyl-1-(4-methylthio-
phenyl)-2-mor-
pholinopropan-1-one
400-600-671868-10-5Acute Tox. 4 (*)
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Wng
H302
H411
   
ab 01.12.2018*):
*) Die harmonisierten Einstufungen dürfen bereits vor dem genannten Datum verwendet werden.
606-041-00-6
2-Methyl-1-(4-methylthio-
phenyl)-2-mor-
pholinopropan-1-on
400-600-671868-10-5Repr. 1B
Acute Tox. 4 *
Aquatic Chronic 2
H360FD
H302
H411
GHS08
GHS07
GHS09
Dgr
H360FD
H302
H411
   
606-042-00-1acetophenone202-708-798-86-2Acute Tox. 4 (*)
Eye Irrit. 2
H302
H319
GHS07
Wng
H302
H319
   
606-043-00-72,4-di-tert-butylcyclohexanone405-340-713019-04-0Skin Irrit. 2
Aquatic Chronic 2
H315
H411
GHS07
GHS09
Wng
H315
H411
   
606-044-00-22,4,6-trimethylbenzophenone403-150-9954-16-5Acute Tox. 4 (*)
Eye Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H302
H319
H400
H410
GHS07
GHS09
Wng
H302
H319
H410
   
606-045-00-8oxadiazon (ISO);
3-[2,4-dichloro-5-(1-methyl-
ethoxy)phenyl]-5-(1,1-di-
methylethyl)-1,3,4-oxadia-
zol-2(3H)-one
243-215-719666-30-9Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410   
606-046-00-3reaction mass of cis- and trans-cyclohexadec-
8-en-1-one
401-700-23100-36-5Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410   
606-047-00-92-benzyl-2-dimethylamino-4-
morpholinobutyrophenone
404-360-3119313-12-1Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410   
606-048-00-42'-anilino-3'-methyl-6'-
dipentylaminospiro(isoben-
zofuran-1(1H),9'-xanthen)-3-one
406-480-1Aquatic Chronic 4H413H413   
606-049-00-X4-(trans-4-propylcyclo-
hexyl)acetophenone
406-700-678531-61-0Skin Sens. 1
Aquatic Chronic 4
H317
H413
GHS07
Wng
H317
H413
   
606-050-00-56-anilino-1-benzoyl-4-(4-tert-
pentylphenoxy)naphto[1,2,3-
de]quinoline-2,7-(3H)-dione
412-480-272453-58-8Aquatic Chronic 2H411GHS09H411   
606-051-00-04-pentylcyclohexanone406-670-461203-83-6Aquatic Chronic 2H411GHS09H411   
606-052-00-64-(N,N-dibutylamino)-2-
hydroxy-2'-carbo-xybenzo-
phenone
410-410-554574-82-2Aquatic Chronic 3H412H412   
606-053-00-1flurtamone (ISO);
(RS)-5-methylamino-2-phenyl-4-
(α, α,α-trifluoro-m-
tolyl)furan-3(2H)-one
96525-23-4Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410   
606-054-00-7Isoxaflutol (ISO);
5-Cyclopropyl-1,2-oxa-zol-4-
yl α,α,α-tri-fluor-2-
mesyl-p-tolyl keton
141112-29-0Repr. 2
Aquatic Acute 1
Aquatic Chronic 1
H361d ***
H400
H410
GHS08
GHS09
Wng
H361d ***
H410
 M = 10
M = 100
 
606-055-00-21-(2,3-dihydro-1,3,3,6-
tetramethyl-1-(1-methylethyl)-
1H-inden-5-yl)ethanone
411-180-992836-10-7Acute Tox. 4 (*)
STOT RE 2 (*)
Aquatic Chronic 2
H302
H373 (*)(*)
H411
GHS08
GHS07
GHS09
Wng
H302
H373 (*)(*)
H411
   
606-056-00-84-chloro-3',4'-dimethoxybenzo-
phenone
404-610-1116412-83-0Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410   
606-057-00-34-propylcyclohexanone406-810-440649-36-3Skin Irrit. 2
Aquatic Chronic 3
H315
H412
GHS07
Wng
H315
H412
   
606-058-00-94'-fluoro-2,2-dimethoxyaceto-
phenone
407-500-121983-80-2Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412
   
606-059-00-42,4-difluoro-α-(1H-1,2,4-
triazol-1-yl)acetophenone hydrochloride
412-390-386386-75-6Acute Tox. 4 (*)
Eye Dam. 1
Skin Sens. 1
H302
H318
H317
GHS05
GHS07
Dgr
H302
H318
H317
   
606-060-00-Xreaction mass of: trans-2,4-dimethyl-2-
(5,6,7,8-tetrahydro-5,5,8,8-
tetramethyl-naphthalene-2-yl)-
1,3-dioxolane;
cis-2,4-dimethyl-2-(5,6,7,8-
tetrahydro-5,5,8,8-tetra-
methyl-naphthalene-2-yl)-1,3-
dioxolane
412-950-7Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410   
606-061-00-5(3-chlorophenyl)-(4-methoxy-3-
nitrophenyl)methanone
423-290-466938-41-8Muta. 2
Aquatic Acute 1
Aquatic Chronic 1
H341
H400
H410
GHS08
GHS09
Wng
H341
H410
   
606-062-00-0tetrahydrothiopyran-3-
carboxaldehyde
407-330-861571-06-0Repr. 1B
Eye Dam. 1
Aquatic Chronic 3
H360D
(*)(*)(*)
H318
H412
GHS08
GHS05
Dgr
H360D
(*)(*)(*)
H318
H412
   
606-063-00-6(E)-3-(2-chlorophenyl)-2-(4-
fluorophenyl)propenal
410-980-5112704-51-5Eye Irrit. 2
Skin Sens. 1
H319
H317
GHS07
Wng
H319
H317
   
606-064-00-1pregn-5-ene-3,20-dione bis(ethylene ketal)407-450-07093-55-2Aquatic Chronic 4H413H413   
606-065-00-71-(4-morpholinophenyl)bu-
tan-1-one
413-790-0Aquatic Chronic 2H411GHS09H411   
606-066-00-2(E)-5[(4-chlorophenyl)methy-
lene]-2,2-dime-thylcyclopen-
tanone
410-440-9164058-20-2Aquatic Chronic 2H411GHS09H411   
606-067-00-8reaction mass of: 1-(2,3,6,7,8,9-hexahydro-
1,1-dimethyl-1H-benz(g)inden-
4-yl)ethanone;
1-(2,3,5,6,7,8-hexahydro-1,1-
dimethyl-1H-benz(f)inden-
4-yl)ethanone;
1-(2,3,6,7,8,9-hexahydro-1,1-
dimethyl-1H-benz(g)inden-
5-yl)ethanone;
1-(2,3,6,7,8,9-hexahydro-3,3-
dimethyl-1H-benz(g)inden-
5-yl)ethanone
414-870-896792-67-5Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410   
606-068-00-32,7,11-trimethyl-13-(2,6,6-
trimethylcyclo-hex-1-en-
1-yl)tridecahexaen-
2,4,6,8,10,12-al
415-770-71638-05-7STOT RE 2 (*)
Skin Sens. 1
Aquatic Chronic 3
H373 (*)(*)
H317
H412
GHS08
GHS07
Wng
H373 (*)(*)
H317
H412
   
606-069-00-9spiro[1,3-dioxolane-2,5'-
(4',4',8',8'-tetramethyl-hexahy-
dro-3',9'-methanonaphthalene)]
415-460-1154171-76-3Aquatic Chronic 2H411GHS09H411   
606-070-00-4butroxydim (ISO);
5-(3-butyryl-2,4,6-trimethyl-
phenyl)-2-[1-(ethoxyimino)pro-
pyl]-3-hydroxycyclohex-2-en-
1-one
414-790-3138164-12-2Repr. 2
Acute Tox. 4 (*)
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H361fd
H302
H315
H400
H410
GHS08
GHS07
GHS09
Wng
H361fd
H302
H315
H410
   
606-071-00-X17-spiro(5,5-dimethyl-1,3-
dioxan-2-yl)androsta-1,4-
diene-3-one
421-050-313258-43-0Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410